About ROSALIND
ROSALIND is a Healthcare company based in San Diego (United States) founded in 2013 by Tim Wesselman. Cloud-based collaborative bioinformatics platform for researchers. ROSALIND has raised $140 thousand across 3 funding rounds from investors including Pasadena Angels, Tech Coast Angels and Wavemaker 360. The company has 23 employees. Its chief executive, as recorded, is Tim Wesselman. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Informatics. Its legal entity is ROSALIND, INC. Its competitors include Cellworks, Genuity Science and Codetta; 3 of its 3 listed competitors have raised funding.
Company details
ROSALIND was founded in 2013 in San Diego, United States, as a provider of cloud-based software in the bioinformatics sector. Researchers are supported through collaborative tools for multi-omic data analysis aimed at drug discovery. Features include data visualization, analytical processing, pathway evaluation, and discovery functions, enabling operations across distributed teams in the life sciences field.
- Headquarters San Diego, United States
- Employees 23
- Founders Tim Wesselman
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website rosalind.bio
- Social LinkedIn X Facebook
- Legal Name Rosalind, Inc.
- Total Equity Funding$140K (USD)
in 3 rounds
- InvestorsPasadena Angels
& 2 more
- Employee Count23
Funding Insights of ROSALIND
ROSALIND has successfully raised a total of $140K across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $140,000
- Total Rounds 3
- First Round $70,000
(Nov 2014)
- Investors Count 3
All 3 funding rounds of ROSALIND with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2018 | Seed | – | Tech Coast Angels, Pasadena Angels | – | |
| Dec 2014 | $70,000 | Seed | – | – | – |
| Nov 2014 | $70,000 | Seed | – | – | – |
3 investors in total: 3 institutional.
Investors in ROSALIND
ROSALIND has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Pasadena Angels, Tech Coast Angels and Wavemaker 360.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Angel Network for companies based in Southern California | techcoastangels.com | Los Angeles, United States | ||
Investments are facilitated by Pasadena Angels in Southern California startups. | 2000 | pasadenaangels.com | Altadena, United States | |
| wavemaker360.com |
Investor details for ROSALIND
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of ROSALIND
12 people are tracked at ROSALIND (9 in leadership, 3 in team); the tracked headcount is 23.
| Name | Role | Group |
|---|---|---|
Tim Wesselman | Founder & CEO | Leadership |
Jean Lozach | Chief Science Officer | Leadership |
Jeremy Davis-Turak | CTO | Leadership |
Ryan S. Friese | Vice President Of Customer Experience | Leadership |
Rob Stults | Director of System Engineering | Leadership |
Abel Gutierrez | Director of Business Development | Leadership |
Walt Segl | Chief Revenue Officer | Leadership |
Angel Stanz | Head Of Innovation | Leadership |
Bryan Chin | VP Engineering | Leadership |
Sam Rogers | Product Analyst | Team |
Qudus Owokoniran | Senior scrum master | Team |
David Cibin | Software Engineer | Team |
Complete people profiles for ROSALIND
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of ROSALIND
3 dated milestones of ROSALIND across 5 years, from founding to its latest funding, stage changes and deals.
- Founded ROSALIND is founded.
- Funding First funding round of $70K.
- Funding Latest funding round, Seed,.
Competitors of ROSALIND
ROSALIND has 3 listed competitors in our database, 3 of them funded. They include Cellworks, Genuity Science and Codetta.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cellworks.life | 2005 | San Jose, United States | $16.52M | Biosimulation platform developed for therapeutic design in life sciences. | ||
| genuitysci.com | 2013 | Boston, United States | $515M | AI-based omics data analysis solutions are provided to researchers. | ||
| codettabio.com | 2021 | Morrisville, United States | $27.28M | Omics clinical data is analyzed through an online platform. |
Detailed competitors of ROSALIND
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of ROSALIND
The website of ROSALIND (rosalind.bio) receives about 9.1K visits a month.
- Monthly visits9.1K
▲ 8.5% vs previous month
Websites whose visitors overlap most with ROSALIND. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
invivoscribe.com | invivoscribe.com | 100% | #2,713,213 | – | |
| nanocellect.com | 98% | 12.8K | #1,939,851 | View details | |
| abeomics.com | 88% | #3,028,425 | View details | ||
| definedbioscience.com | 29% | 2.1K | #8,065,147 | View details | |
| empiri.co | 29% | 2.5K | #7,036,136 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 10 similar websites and full traffic analytics for ROSALIND
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 10 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as ROSALIND (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Rosalind
Complete news archive for ROSALIND
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ROSALIND
ROSALIND was founded in 2013 and raised its 1st funding round 1 year after it was founded.
ROSALIND is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Tim Wesselman is the CEO of ROSALIND, as recorded in our data. They have also founded this company.
ROSALIND is a funded company, having raised a total of $140K across 3 funding rounds to date. The company's 1st funding round was a Seed of $70K, raised on Nov 2014.
ROSALIND has 23 employees.
ROSALIND was founded in 2013 in San Diego, United States, as a provider of cloud-based software in the bioinformatics sector. Researchers are supported through collaborative tools for multi-omic data analysis aimed at drug discovery. Features include data visualization, analytical processing, pathway evaluation, and discovery functions, enabling operations across distributed teams in the life sciences field.
ROSALIND's top competitors include Cellworks, Codetta and Genuity Science.
ROSALIND has 3 investors. Key investors include Pasadena Angels, Tech Coast Angels, and Wavemaker 360.
ROSALIND operates through Rosalind, Inc..